Published on
Apr 29, 2025
Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling
Non-small cell lung cancer (NSCLC) is the predominant lung cancer subtype in the United States, constituting approximately 85% of all diagnosed cases (1,2). Two frequently altered driver mutations in NSCLC are gene mutations in the proto-oncogene KRAS, …
Source:
eLife
-
Pending
